FindTrial
Sign In

Comparison of two different doses of intrathecal buprenorphine with 0.75 percent hyperbaric ropivacaine in elective caesarean sections.

Comparison of two different doses of intrathecal buprenorphine with 0.75% hyperbaric ropivacaine in elective caesarean section for post operative analgesia. A randomized clinical trial. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103092
Enrollment
86
Registered
2026-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Pratibha S D
Lead Sponsor
Dr Harish T
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women of 18 to 40 years scheduled for elective caesarean section.

Exclusion criteria

Exclusion criteria: Contraindications to spinal anaesthesia, opioid allergy, pregnancy related complications like preeclampsia, known systemic illness like uncontrolled hypertension, uncontrolled diabetes mellitus, severe hepatic and renal diseases.

Design outcomes

Primary

MeasureTime frame
To assess the onset and duration of motor and sensory blockade and to evaluate the pain intensity using VAS scoreTimepoint: To check pain intensity post surgery at 1, 2, 4, 6, 12, 24 hours—

Secondary

MeasureTime frame
NilTimepoint:—

Countries

India

Contacts

Public ContactDr Pratibha S D

Shri B. M. Patil Medical College Hospital and Research Centre

Pratibhakaradi@gmail.com9036110082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026